{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T13:33:28Z","timestamp":1758634408927,"version":"3.40.5"},"reference-count":16,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.amjcard.2018.06.015","type":"journal-article","created":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T17:47:21Z","timestamp":1533750441000},"page":"1047-1050","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Usefulness and Safety of Rivaroxaban in Patients Following Isolated Mitral Valve Replacement With a Mechanical Prosthesis"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1506-0327","authenticated-orcid":false,"given":"Andr\u00e9 R.","family":"Dur\u00e3es","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0125-2261","authenticated-orcid":false,"given":"Yasmin de S.L.","family":"Bitar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luiza G.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline C.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor S.","family":"Schonhofen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Admir\u00e7o L.","family":"Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Roever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2018.06.015_bib0001","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(09)60780-7","article-title":"Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends","volume":"374","author":"Sun","year":"2009","journal-title":"Lancet"},{"issue":"9990","key":"10.1016\/j.amjcard.2018.06.015_bib0002","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0140-6736(15)60243-4","article-title":"Pharmacology of antithrombotic drugs: an assessment of oral antiplatelet and anticoagulant treatments","volume":"386","author":"Mega","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2018.06.015_bib0003","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1056\/NEJMoa1300615","article-title":"Dabigatran versus warfarin in patients with mechanical heart valves","volume":"369","author":"Eikelboom","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2018.06.015_bib0004","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/0735-1097(94)00563-6","article-title":"High risk of thromboemboli early after bioprosthetic cardiac valve replacement","volume":"25","author":"Heras","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2018.06.015_bib0005","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s11239-011-0621-6","article-title":"Comparison of unfractionated heparin, low-molecular-weight heparin, low-dose and high-dose rivaroxaban in preventing thrombus formation on mechanical heart valves: results of an in vitro study","volume":"32","author":"Kaeberich","year":"2011","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.amjcard.2018.06.015_bib0006","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/ejcts\/ezt545","article-title":"Effectiveness of rivaroxaban for thromboprophylaxis of prosthetic heart valves in a porcine heterotopic valve model","volume":"45","author":"Greiten","year":"2014","journal-title":"Eur J CardiothoracSurg"},{"key":"10.1016\/j.amjcard.2018.06.015_bib0007","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/ejcts\/ezt513","article-title":"Initial experience with rivaroxaban in mechanical valve prosthesis in an animal model","volume":"45","author":"Aramendi","year":"2014","journal-title":"Eur J CardiothoracSurg"},{"key":"10.1016\/j.amjcard.2018.06.015_bib0008","first-page":"236","article-title":"A method to determine the optimal intensity of oral anticoagulant therapy","volume":"69","author":"Rosendaal","year":"1993","journal-title":"ThrombHaemost"},{"key":"10.1016\/j.amjcard.2018.06.015_bib0009","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1161\/CIRCULATIONAHA.116.026854","article-title":"Time in the therapeutic range for patients taking warfarin in clinical trials: useful, but also misleading, misused, and overinterpreted","volume":"135","author":"Reiffel","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2018.06.015_bib0010","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/0735-1097(94)90644-0","article-title":"Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo","volume":"23","author":"Fatkin","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2018.06.015_bib0011","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":". Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.amjcard.2018.06.015_bib0012","doi-asserted-by":"crossref","first-page":"73","DOI":"10.14797\/mdcj-13-2-73","article-title":"Mechanical valve thrombosis on rivaroxaban: are novel anticoagulants really an option?","volume":"13","author":"Kumar","year":"2017","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"10.1016\/j.amjcard.2018.06.015_bib0013","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1016\/j.jacc.2016.09.958","article-title":"Prosthetic heart valve thrombosis","volume":"68","author":"Dangas","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.amjcard.2018.06.015_bib0014","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2015-000279","article-title":"NOACs versus warfarin for stroke prevention in patients with AF: a systematic review and meta-analysis","volume":"3","author":"Hicks","year":"2016","journal-title":"Open Heart"},{"key":"10.1016\/j.amjcard.2018.06.015_bib0015","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.jacc.2016.12.038","article-title":"Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease","volume":"69","author":"Renda","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2018.06.015_bib0016","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/ATVBAHA.117.309223","article-title":"Anticoagulation for mechanical heart valves: will Oral Factor Xa inhibitors be effective","volume":"37","author":"Chan","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914918312542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914918312542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T17:43:33Z","timestamp":1538070213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914918312542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0002914918312542"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2018.06.015","relation":{},"ISSN":["0002-9149"],"issn-type":[{"type":"print","value":"0002-9149"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Usefulness and Safety of Rivaroxaban in Patients Following Isolated Mitral Valve Replacement With a Mechanical Prosthesis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2018.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}